Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037476 · ClinicalTrials.gov registry record · NA
Personalized Health Assessment Related to Medications (Project PHARM)
A NA study of Substance Abuse and Feedback, Psychological, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 843
- Enrollment target
- 1
- Study location
NCT03037476: Completed NA study of Substance Abuse and Feedback, Psychological, sponsored by University of Washington.
NCT03037476 is a NA study of Substance Abuse and Feedback, Psychological that has completed, run by University of Washington. The registered enrollment target is 843 participants, below the 5,245-participant average among 58 other Substance Abuse trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03037476, a NA study of Substance Abuse and Feedback, Psychological, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 843 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will adapt an evidence based intervention for alcohol and other drugs and evaluate its efficacy on Prescription Stimulant Medication (PSM) misuse in a web-based format for use with college students who have misused PSMs.
Primary Outcome
Assesses frequency of non-medical use of prescription stimulant medications. Change was calculated from two time points as the value at the later time point minus the value at the earlier time point (e.g., value at 6 months minus value at baseline and the value at 12 months minus the value at baseline).
Conditions Studied
Interventions
- BEHAVIORAL Web-based PFI
- BEHAVIORAL Assessment Only
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 843 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
What the finished NCT03037476 record still lists
NCT03037476 is an interventional study that assigns participants to a tested intervention. The registered 843 participants enrollment target is mid-sized for trials with a published cap, below the 5,245-participant average among 58 other Substance Abuse trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Web-based PFI is the first listed.
NCT03037476 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03037476 about?
NCT03037476 is a clinical study titled "Personalized Health Assessment Related to Medications (Project PHARM)". This research will adapt an evidence based intervention for alcohol and other drugs and evaluate its efficacy on Prescription Stimulant Medication (PSM) misuse in a web-based format for use with college students who have misused PSMs.
What is the current status of trial NCT03037476?
This trial is currently completed. It is a NA study. The enrollment target is 843 participants. The study started on 2017-03-30. Estimated completion is 2021-12-15.
What conditions does trial NCT03037476 study?
This clinical trial studies the following conditions: Substance Abuse, Feedback, Psychological, Clinical Trial.
What interventions are being tested in trial NCT03037476?
The interventions under investigation include: Web-based PFI (BEHAVIORAL), Assessment Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03037476?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03037476 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03037476's enrollment target sits among peer trials
843 7th of 58 higher than 52 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06439979 · 843 participants · NA
Rural Adult and Youth Sun Protection Study
- NCT06747949 · 844 participants · Phase 3
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- NCT06027788 · 842 participants · NA
CTSN Embolic Protection Trial
- NCT02757859 · 845 participants · NA
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI